| Title : Hepatic and serologic toxicity of systemic interleukin-2 and\/or interferon-alpha. Evidence of a risk-benefit advantage of subcutaneous therapy - Schomburg_1994_Am.J.Clin.Onc_17_199 |
| Author(s) : Schomburg A , Kirchner H , Lopez-Hanninen E , Menzel T , Rudolph P , Korfer A , Fenner M , Poliwoda H , Atzpodien J |
| Ref : American Journal of Clinical Oncology , 17 :199 , 1994 |
| PubMedID: 7910716 |